Bioethics in Faith and Practice, Volume 2, Number 1

4 Kuruvilla ⦁ CRISPR: Race to the Cure “too high”? Should germ line therapies ever be permitted, or are the risks to subsequent generations simply too great? Once again, technology is moving faster than the ethical discussions surrounding its proper and wise stewardship. We dare not wait too long to make our voices heard. i Cyranoski, David. “CRISPR Gene Editing Tested in a Person for the First Time.” Nature News , November 15, 2016. Accessed December 14, 2016. ii Reardon, Sarah. "First CRISPR Clinical Trial Gets Green Light from US Panel." Nature News , June 22, 2016. Accessed December 14, 2016. iii Reardon, Sarah. “Leukaemia success heralds wave of gene-editing therapies.” Nature News , November 5, 2015. Accessed December 14, 2016. iv Pearlman, Alex. Scientists Argue the US Ban on Human Gene Editing Will Leave It Behind. Motherboard, August 4, 2016. Accessed December 14, 2016. Bibliography Cyranoski, David. “CRISPR Gene Editing Tested in a Person for the First Time.” Nature News , November 15, 2016. Accessed December 14, 2016. Pearlman, Alex. Scientists Argue the US Ban on Human Gene Editing Will Leave It Behind. Motherboard, August 4, 2016. Accessed December 14, 2016. Reardon, Sarah. "First CRISPR Clinical Trial Gets Green Light from US Panel." Nature News , June 22, 2016. Accessed December 14, 2016. Reardon, Sarah. “Leukaemia success heralds wave of gene-editing therapies.” Nature News , November 5, 2015. Accessed December 14, 2016.